While the medication has transformed weight loss for millions, the rules for breastfeeding mothers are more complex than a simple yes or no. As of early 2026, the official stance from the FDA remains cautious
On the compounding side, any new branded GLP-1 peptide entering Phase 3 adds heat to an already contentious space
The FDA approval process serves as the primary gateway for North American market entry
This multi-faceted mechanism makes it effective for glycaemic control in type 2 diabetes, and it has also been approved at higher doses (under the brand name Wegovy) for weight management in specific patient populations, accessed through specialist weight management services according to NICE technology appraisal guidance
It offers several benefits, including lowering blood sugar levels, promoting weight loss, improving cardiovascular health, and managing kidney disease
ShunguDCWeiduschatNMurroughJWMaoXPillemerSDykeJPet al